GSK-VEG108844



Study VEG108844, A study of Pazopanib versus Sunitinib in the Treatment of Subjects with Locally Advanced and/or Metastatic Renal Cell Carcinoma
pazopanib
VEG108844
NCT00720941
Carcinoma, Renal Cell
Phase 3
 
September 2013